Corpus ID: 53124023

Lapachol and Its D erivatives as Potential D rug s for C an cer T reatment

@inproceedings{Nepomuceno2016LapacholAI,
  title={Lapachol and Its D erivatives as Potential D rug s for C an cer T reatment},
  author={J. C. Nepomuceno},
  year={2016}
}
Natural products extracted from plants have significantly contributed to the development of various medications used clinically in traditional medicine (Newman et al., 2003). Prospection of biological materials in plants, in areas of wide biodiversity in tropical and subtropical regions, provides chemical diversity for obtaining products for the development of new drugs (Kinghorn et al., 2003). Natural products have been widely used in treatment of diseases in popular medicine. Based on this… Expand

References

SHOWING 1-10 OF 54 REFERENCES
The search for novel anticancer agents: a differentiation-based assay and analysis of a folklore product.
TLDR
An in vitro assay using the murine erythroleukemia (clone 3-1) cells for the analysis of antineoplastic activity in natural products and indicates the presence of lapachol, a vitamin K antagonist that might target such vitamin K-dependent reactions as the activation of a ligand for the Axl receptor tyrosine kinase. Expand
Lapachol: An overview
Lapachol is a naphthoquinone that was first isolated by E. Paterno from Tabebuia avellanedae (Bignoniaceae) in 1882. A wide spectrum of therapeutic activities have been attributed to lapachol or itsExpand
In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum.
TLDR
The antimalarial activity of the naphthoquinones against drug-resistant strains was superior to that of chloroquine and quinine which were used as controls and will be promising candidates for treatment of human malaria particularly since they are easily synthesized. Expand
Red Lapacho (Tabebuia impetiginosa)--a global ethnopharmacological commodity?
TLDR
The bioscientific evidence for products derived from Tabebuia impetiginosa is insufficient and one of the core challenges of future research will be--based on the recognition of the drug's widespread use--to establish appropriate quality control procedures. Expand
Health-promoting properties of common herbs.
  • W. Craig
  • Biology, Medicine
  • The American journal of clinical nutrition
  • 1999
TLDR
The volatile essential oils of commonly used culinary herbs, spices, and herbal teas inhibit mevalonate synthesis and thereby suppress cholesterol synthesis and tumor growth. Expand
Demonstration of the lapachol as a potential drug for reducing cancer metastasis.
TLDR
This study aims to examine the molecular and morphological alterations caused by lapachol treatment, as well as its effects on the intrinsic tissue invasive property of HeLa cells in CAM model, and concludes that Lapachol has a great potential of application in fighting metastasis. Expand
Sulindac Compounds Facilitate the Cytotoxicity of β-Lapachone by Up-Regulation of NAD(P)H Quinone Oxidoreductase in Human Lung Cancer Cells
TLDR
Sulindac and its metabolites synergistically increase the anticancer effects of β-lapachone primarily by increasing NQO1 activity and expression, and these two drugs may provide a novel combination therapy for lung cancers. Expand
LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells
TLDR
The data suggest that LQB-118 has a potent anti-CML activity that can overcome multifactorial drug resistance mechanisms, making this compound a promising new anti- CML agent. Expand
Natural products as sources of new drugs over the period 1981-2002.
TLDR
From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well, and in the area of cancer, the percentage of small molecule, new chemical entities that are nonsynthetic has remained at 62% averaged over the whole time frame. Expand
The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1
TLDR
The finding that β-lapachone has IDO1 inhibitory activity adds a new dimension to its potential utility as an anti-cancer agent distinct from its cytotoxic properties, and suggests that a synergistic benefit can be achieved from its combined cytot toxic and immunologic effects. Expand
...
1
2
3
4
5
...